[go: up one dir, main page]

FI19991806L - Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus - Google Patents

Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus

Info

Publication number
FI19991806L
FI19991806L FI991806A FI19991806A FI19991806L FI 19991806 L FI19991806 L FI 19991806L FI 991806 A FI991806 A FI 991806A FI 19991806 A FI19991806 A FI 19991806A FI 19991806 L FI19991806 L FI 19991806L
Authority
FI
Finland
Prior art keywords
preparation
active agent
biologically active
controlled release
novel compositions
Prior art date
Application number
FI991806A
Other languages
English (en)
Swedish (sv)
Other versions
FI19991806A7 (fi
Inventor
Manja Ahola
Eija Saeilynoja
Jukka Salonen
Risto Penttinen
Antti Yli-Urpo
Original Assignee
Yli Urpo Antti
Jukka Salonen
Eija Saeilynoja
Manja Ahola
Risto Penttinen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yli Urpo Antti, Jukka Salonen, Eija Saeilynoja, Manja Ahola, Risto Penttinen filed Critical Yli Urpo Antti
Priority to FI19991806A priority Critical patent/FI19991806A7/fi
Priority to CA002379982A priority patent/CA2379982A1/en
Priority to JP2001518061A priority patent/JP2003507427A/ja
Priority to DK00954693T priority patent/DK1206268T3/da
Priority to AT00954693T priority patent/ATE279928T1/de
Priority to PCT/FI2000/000710 priority patent/WO2001013924A1/en
Priority to DE60015151T priority patent/DE60015151T2/de
Priority to ES00954693T priority patent/ES2230141T3/es
Priority to EP00954693A priority patent/EP1206268B1/en
Priority to AU67054/00A priority patent/AU6705400A/en
Priority to US10/069,145 priority patent/US7112339B1/en
Publication of FI19991806L publication Critical patent/FI19991806L/fi
Publication of FI19991806A7 publication Critical patent/FI19991806A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI19991806A 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus FI19991806A7 (fi)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI19991806A FI19991806A7 (fi) 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
CA002379982A CA2379982A1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
JP2001518061A JP2003507427A (ja) 1999-08-25 2000-08-22 生物活性物質の制御放出のための新規組成物、及びその製造
DK00954693T DK1206268T3 (da) 1999-08-25 2000-08-22 Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse
AT00954693T ATE279928T1 (de) 1999-08-25 2000-08-22 Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben
PCT/FI2000/000710 WO2001013924A1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
DE60015151T DE60015151T2 (de) 1999-08-25 2000-08-22 Neue zusammensetzungen zur kontrollierten freigabe eines biologisch wirksamen mittels sowie die herstellung derselben
ES00954693T ES2230141T3 (es) 1999-08-25 2000-08-22 Nuevas composiciones para la liberacion de un agente biologicamente activo y procedimiento para su preparacion.
EP00954693A EP1206268B1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
AU67054/00A AU6705400A (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
US10/069,145 US7112339B1 (en) 1999-08-25 2000-08-22 Compositions for controlled release of a biologically active agent, and the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI19991806A FI19991806A7 (fi) 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus

Publications (2)

Publication Number Publication Date
FI19991806L true FI19991806L (fi) 2001-02-26
FI19991806A7 FI19991806A7 (fi) 2001-02-26

Family

ID=8555195

Family Applications (1)

Application Number Title Priority Date Filing Date
FI19991806A FI19991806A7 (fi) 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus

Country Status (11)

Country Link
US (1) US7112339B1 (fi)
EP (1) EP1206268B1 (fi)
JP (1) JP2003507427A (fi)
AT (1) ATE279928T1 (fi)
AU (1) AU6705400A (fi)
CA (1) CA2379982A1 (fi)
DE (1) DE60015151T2 (fi)
DK (1) DK1206268T3 (fi)
ES (1) ES2230141T3 (fi)
FI (1) FI19991806A7 (fi)
WO (1) WO2001013924A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
CA2442284C (en) 2001-04-04 2009-10-06 Delsitech Oy Biodegradable carrier and method for preparation thereof
WO2003095515A2 (en) * 2002-05-07 2003-11-20 The Research Foundation Of State University Of New York A method to rapidly prepare and screen formulations and compositions containing same
DE10249874A1 (de) * 2002-10-25 2004-05-06 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Antiadhäsive Beschichtung zur Ausrüstung von Wundverbänden
US7923030B2 (en) 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
EA008771B1 (ru) 2003-07-31 2007-08-31 Сол-Джел Текнолоджиз Лтд. Микрокапсулы, заполненные активными ингредиентами, и способ их приготовления
CA2555179A1 (en) * 2004-02-27 2005-09-09 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived sio2
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
KR101158162B1 (ko) 2005-08-02 2012-06-19 솔-겔 테크놀로지스 리미티드 수 불용성 성분을 금속 산화물로 피복시키는 방법
ES2763829T3 (es) 2007-02-01 2020-06-01 Sol Gel Tech Ltd Método para preparar partículas que comprenden un revestimiento de óxido de metal
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
US11458105B2 (en) 2008-12-04 2022-10-04 International Flavors & Fragrances Inc. Hybrid fragrance encapsulate formulation and method for using the same
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
KR101070345B1 (ko) 2009-07-03 2011-10-06 서울대학교산학협력단 생체활성인자가 포함된 유무기 혼성 복합 코팅층, 생체 이식용 임플란트 및 그 제조방법
MX369325B (es) * 2011-03-18 2019-11-05 Int Flavors & Fragrances Inc Microcapsulas producidas a partir de precursores de sol-gel mezclados y metodos para producir las mismas.
CA2858161C (en) 2011-12-05 2020-03-10 Incept, Llc Medical organogel processes and compositions
JP2015537029A (ja) 2012-11-14 2015-12-24 ダブリュー・アール・グレース・アンド・カンパニー−コーンＷ Ｒ Ｇｒａｃｅ ＆ Ｃｏ−Ｃｏｎｎ 生物学的に活性な物質及び不規則性無機酸化物を含有する組成物
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
HRP20251185T1 (hr) 2017-07-12 2025-11-21 Sol-Gel Technologies Ltd. Tvari koje obuhvaćaju tretinoin u kapsulama

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804318A (en) * 1995-10-26 1998-09-08 Corvita Corporation Lubricious hydrogel surface modification
JP3488965B2 (ja) * 1996-05-21 2004-01-19 日本山村硝子株式会社 ゾル−ゲル法による独立膜の製造方法
ES2244998T5 (es) 1996-05-29 2009-06-15 Delsitech Oy Oxidos solubles para aplicaciones biologicas.
US7897166B1 (en) * 1999-02-22 2011-03-01 Delsitech Oy Biodegradable ceramic fibres from silica sols

Also Published As

Publication number Publication date
DE60015151D1 (de) 2004-11-25
CA2379982A1 (en) 2001-03-01
ES2230141T3 (es) 2005-05-01
WO2001013924A8 (en) 2001-11-01
JP2003507427A (ja) 2003-02-25
US7112339B1 (en) 2006-09-26
DK1206268T3 (da) 2005-01-10
EP1206268A1 (en) 2002-05-22
EP1206268B1 (en) 2004-10-20
AU6705400A (en) 2001-03-19
ATE279928T1 (de) 2004-11-15
WO2001013924A1 (en) 2001-03-01
DE60015151T2 (de) 2006-02-16
FI19991806A7 (fi) 2001-02-26

Similar Documents

Publication Publication Date Title
FI19991806L (fi) Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
AR026045A1 (es) Formulaciones de liberacion prolongada de derivados de eritromocina
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
AU2093101A (en) Compositions for efficient release of active ingredients
NO20021540D0 (no) Sammensetninger med kontrollert frigivelse omfattende nimesulfid
FI19991852L (fi) Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
EE04799B1 (et) Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
DE69822209D1 (de) ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON
AR027907A1 (es) Composicion de liberacion controlada
NO982324L (no) Preparat med regulert avgivelse av biologisk aktiv forbindelse
AU2268301A (en) Novel urea compounds, compositions and methods of use and preparation
AU2003215245A8 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
DE10084522T1 (de) Hautfreundliche absorptionsfähige Artikel und Zusammensetzungen
EE200200342A (et) Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend
ZA988718B (en) Drug formulation having controlled release of active compound
EE200100706A (et) A-grupi streptogramiinide derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
AU2001227030A1 (en) Pharmaceutical composition for controlled release of an active ingredient
HUP0203226A3 (en) Pharmaceutical composition comprising benzamide derivative as active ingredient
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
EE200900049A (et) Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina